Unilateral hypoplastic kidney - a novel highly penetrant feature of familial juvenile hyperuricaemic nephropathy by Lucy A Plumb et al.
Plumb et al. BMC Nephrology 2014, 15:76
http://www.biomedcentral.com/1471-2369/15/76CASE REPORT Open AccessUnilateral hypoplastic kidney - a novel highly
penetrant feature of familial juvenile
hyperuricaemic nephropathy
Lucy A Plumb1, Matko Marlais1, Agnieszka Bierzynska2, Howard Martin3, Kim Brugger3, Stephen Abbs3
and Moin A Saleem4*Abstract
Background: Familial juvenile hyperuricaemic nephropathy is a rare inherited nephropathy with genetic
heterogeneity. Categorised by genetic defect, mutations in uromodulin (UMOD), renin (REN) and hepatocyte nuclear
factor-1β (HNF-1β) genes as well as linkage to chromosome 2p22.1-21 have previously been identified. Knowledge
of the genetics of this phenotype has provided important clues to developmental pathways in the kidney.
Case presentation: We report a novel phenotype, with the typical features of hyperuricemia and renal
deterioration, but with the additional unexpected feature of unilateral renal hypoplasia. Mutation analyses of the
existing known genes and genetic loci were negative indicating a new monogenic cause. Interestingly two cousins
of the index case did not share the latter feature, suggesting a modifier gene effect.
Conclusion: Unilateral renal hypo/aplasia is usually sporadic and relatively common, with no genetic cause to date
identified. This reported pedigree reveals the possibility that a new, unknown renal developmental gene may be
implicated in the FJHN phenotype.
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Familial juvenile hyperuricaemic nephropathy is a rare
cause of renal disease in children. It is inherited in an
autosomal dominant manner and is characterised by
hyperuricaemia and gout, inevitably progressing to end-
stage renal failure. The pathogenesis of FJHN appears to
be an impairment of urate clearance relative to creatin-
ine (fractional excretion, FEur), which may present before
adolescence [1]. The ensuing hyperuricaemia often de-
velops after puberty, and may be clinically silent or mani-
fest as gout [2]. Histological findings on biopsy suggest a
chronic non-specific tubulointerstitial nephropathy [3].
Although the exact mechanism of renal dysfunction is
unclear, function gradually declines and end-stage renal
disease may develop within 10-15 years [4]. We present
a family with FJHN whose novel renal phenotype may* Correspondence: m.saleem@bristol.ac.uk
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reproduction in any medium, provided the orhelp to provide further understanding of the genetics sur-
rounding renal hypoplasia.Case presentation
A 16 year old male was brought to our attention following
concerns by his GP of a strong family history of renal dis-
ease. He is a fit and healthy teenager who has had no
significant health problems in the past. In the family
(Figure 1, Table 1) the patient’s mother had been diag-
nosed three years previously with renal failure requiring
peritoneal dialysis and subsequent transplantation. She
was noted upon further investigation to have a small right
kidney on ultrasound. The patient’s maternal aunt was
also in established renal failure and in addition to one
small kidney on ultrasound suffered with gout. She has
two sons aged 18 and 20 years with renal impairment,
both with raised uric acid levels, but no evidence of renal
hypoplasia. Her daughter has shown no sign of renal dis-
ease. Two maternal uncles have not had kidney problems,
and neither have maternal grandparents. The patient inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 The family pedigree studied. Arrow points to the index case. (Partly shaded: renal impairment and hyperuricaemia/gout; fully
shaded- renal impairment, hyperuricaemia/gout and unilateral renal hypoplasia).
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family members have undergone a native renal biopsy.
Upon initial examination the patient was noted to ap-
pear well. His blood pressure of 122/55 was within normal
centile range for his height and age. An ultrasound re-
vealed a small right kidney measuring 8.2 cm which was
otherwise unremarkable, as well as a normal sized al-
though slightly echogenic left kidney, measuring 13.0 cm.
The bladder and ureters were reported as normal. Initial
blood tests revealed an estimated glomerular filtration rate
(GFR) of 64 ml/min/1.73 m2, although this has since de-
clined (table 1). Urinalysis was normal. Uric acid was ini-
tially 430 μmol/L, however on repeat testing was raised at
506 μmol/L (normal reference range 200-430 μmol/L).
The patient is currently being seen at regular intervals to
monitor for deterioration in renal function.
In view of the apparent autosomal dominant transmis-
sion of this phenotype, further blood samples from the af-
fected family members were sent to test for uromodulinTable 1 Clinical characteristics of family members
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10 21 No data N
11 16 102 1(UMOD) and hepatocyte nuclear factor-1β (HNF1β) mu-
tations, which were negative. The index case was also
screened for mutations in the renin (REN) gene and the
2p22.1-p21 region using exome sequencing, however, no
pathological variants were found (please see supplemen-
tary data for methodology and results).
Conclusions
FJHN is an autosomal dominant condition characterised
by a hypoexcretion of urate leading to hyperuricaemia,
gout and renal disease. Renal impairment is of relatively
late onset, usually occurring between 15-30 years of age
[4]. Progression to end stage renal impairment may de-
velop within 10-15 years, although may be slowed by early
introduction of allopurinol [5]. Ultrasound findings of
note include reduction in renal size with abnormal echo-
genicity, and in some cases cysts have been reported [6,7].
Diagnosis of FJHN is a clinical one, however as our
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genetic defect. There are at present three types of FJHN.
Type one (FJHN1) is associated with heterozygous muta-
tions in the uromodulin (UMOD) gene on chromosome
16p12.3 (MIM 191845) [3,6-9]. Type two (FJHN2) is asso-
ciated with mutations in the renin gene (REN) on chromo-
some 1q32 (MIM 179820) [10], and type three (FJHN3)
has been mapped to 2p22.1-21 (MIM 614227) [11]. An
atypical variant of FJHN, associated with diabetes and
renal cysts, has been linked to mutations in HNF-1β on
chromosome 17q12 (MIM 189907) [12].
We describe a family with familial juvenile hyperuri-
caemic nephropathy (FJHN) that requires our attention
for several reasons. Firstly, there is the penetrant feature
of a single hypoplastic kidney alongside a normal sized
kidney in three out of the five affected family members.
A unilateral hypoplastic kidney in a single case of FJHN
has previously been described [6]. To our knowledge this
is the first report to describe renal hypoplasia as a sig-
nificant feature of the FJHN phenotype in one pedigree.
Secondly our kindred have shown no evidence of patho-
logical mutations in either genes or genetic loci associ-
ated with the FJHN phenotype. Two of the major genes
implicated in FJHN, uromodulin (UMOD) and hepato-
cyte nuclear factor 1β (HNF1β), have previously been
linked to a role in nephrogenesis [6,13-15]. Negative
screening in this case suggests that unknown key genes
may play a crucial role in the formation of the kidney as
well as in the development of FJHN.
Renal hypoplasia is defined as abnormally small kid-
neys (greater than two standard deviations below the ex-
pected mean when correlated with age or other growth
parameters) with normal morphology but reduced neph-
ron number [16]. Whilst true diagnosis relies on histo-
logical examination, in reality the diagnosis is often made
by non-invasive diagnostic tools such as ultrasound
[16,17]. UK data suggests renal hypoplasia and/or dyspla-
sia accounts for almost a third of all cases of end stage
renal disease in the paediatric population [18]. Calculating
the true incidence of renal hypoplasia however may be dif-
ficult owing to the fact that the terms renal dysplasia
(small kidneys with tissue maldifferentiation) and renal
hypoplasia are often interchangeably and incorrectly used.
Nephrourogenesis commences at four weeks of gesta-
tion, when signals from metanephric mesenchyme (MM)
initiate the formation of the ureteric bud (UB) from the
nearby Wolffian duct. Contact and interactions between
the cell lineages subsequently lead to proliferation and
epithelial transformation of the MM, which goes on to
form a functional nephron. At the same time, branching
of the distal UB occurs to form the mature collecting sys-
tem [15,16]. The whole process is coordinated by complex
interplay between various transcription, growth factors
and co-factors that are referred to as renal developmentalgenes (RDGs). There is now growing evidence to suggest
that mutations in several key RDGs may underlie the
pathogenesis of renal hypoplasia, leading to aberrant in-
teractions between the embryonic ureteric bud and the
metanephric mesenchyme during fetal development [19].
Studies into cases of ‘non-syndromic’ renal hypoplasia
have identified mutations in several key genes which in-
clude PAX2, SIX2, BNP4, SALL1, UMOD and TCF2.
Unilateral renal hypoplasia has been reported as a sin-
gle feature of low penetrance in a small number of
studies; however extrarenal features suggestive of FJHN
are lacking [13,20]. Of the aforementioned RDGs, TCF2
and UMOD have been linked to HNFJ through muta-
tion screening [3,6,8,9,12].
TCF2 is the gene encoding for HNF1β, an embryonic
transcription factor expressed in the liver, kidney, and
pancreas [14]. Mutations in HNF1β have been identified
in families with FJHN particularly those with atypical
features such as renal cysts or other anomalies of renal
development. Although the mechanism for the pheno-
type in these patients is unclear, it has been speculated
that HNF1β which is expressed at an early stage in the
proximal tubule may reduce transcription of human
urate transporters, although this is yet to be proven [12].
HNF1β is known to induce UMOD, a gene encoding the
protein uromodulin. Several uromodulin mutations have
been discovered in patients with the FJHN phenotype, now
categorised as FJHN type 1 [3,6-9]. Also known as Tamm-
Horsfall glycoprotein, studies suggest uromodulin plays a
vital role in maintaining the low water permeability and
countercurrent gradient of the medullary loop [8,21]. De-
fects therefore lead to an increase in urinary salt and water
excretion, and consequently an increase in uric acid re-
absorption in the proximal tubule.
Mutations in the renin gene have been identified in three
families with a FJHN phenotype. It is proposed that high
expression of the mutant REN gene in the juxtaglomerular
cells over time results in renin-angiotensin dysregulation
with reduced renin synthesis, apoptosis and nephron loss
leading to progressive renal failure [10]. While normal
renal size has been reported in these families, mice studies
have shown that complete ablation of renin-expressing
cells is associated with small and morphologically abnor-
mal kidneys, suggesting renin is necessary to maintain
morphological integrity during kidney development [22].
Piret et al. identified a genetic region of up to 28 candi-
date genes on 2p22.1-21 linked to five families with FJHN
which has since been termed FJHN3. It is speculated that
mutations within this region may account for the majority
of FJHN cases that prove negative for UMOD, REN or
HNF-1β mutations [11]. While it is unclear how the
underlying mutation leads to the resultant phenotype, a
bilateral reduction in kidney size was seen in 3/16 cases
that were linked the FJHN3 locus.
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trant feature of a renal developmental anomaly in three
out of five affected members may implicate an as yet un-
identified developmental gene in the pathogenesis of
FJHN. The genetic heterogeneity of the condition is well
described, and our pedigree supports the possibility of a
new, unidentified gene implicated in both the FJHN
phenotype as well as the development of renal hypopla-
sia [3,4,9]. Other possibilities for identifying candidate
genes may be suggested based on the clinical and bio-
chemical findings known to patients with FJHN. As one
of the biochemical hallmarks of the disease is hypoexcre-
tion, it has been hypothesised that a defect in urate
transport within the proximal renal tubule, where 90%
of urate is reabsorbed, may be the underlying mechan-
ism for disease [12]. So far however no significant cor-
relation with urate transporter genes, including URAT1
and hUAT has been identified [3].
What remains to be identified is the causal gene for
the phenotype described in our index case and his af-
fected family members. The overwhelming likelihood
here is of a dominantly inherited single gene defect, ra-
ther than multiple genetic defects or multifactorial ele-
ments at play due to the precise inheritance seen and
highly penetrant feature of a unilateral hypoplastic kid-
ney. Interestingly, the lack of a unilateral small kidney in
the two cousins of our index case, who both have exactly
the same renal impairment phenotype otherwise, would
imply the effect of a modifier gene to cause this feature.
The genetic identification may have major implications
for the commonly seen isolated hypoplastic/absent kidney
phenotype in children and adults, for which no candidate
gene has to date been identified. It is important to report
this pedigree, as the collection of further pedigrees world-
wide will help simplify identification of the responsible
gene, particularly given the possibility now of complete
exome sequencing for affected patients. This will also pro-
vide insight into the disease processes present in FJHN,
enabling a greater understanding of how a phenotype that
often presents later in life is associated with a renal devel-
opmental anomaly. Discovery of the mutation will provide
an explanation to family members; will allow appropriate
counselling for future generations as well as enable clini-
cians to implement management strategies to prevent
disease progression.Consent
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